Ret rescues mitochondrial morphology and muscle degeneration of Drosophila Pink1 mutants
Open Access
- 29 January 2014
- journal article
- research article
- Published by Springer Nature in The EMBO Journal
- Vol. 33 (4) , 341-355
Abstract
Parkinson's disease (PD)‐associated Pink1 and Parkin proteins are believed to function in a common pathway controlling mitochondrial clearance and trafficking. Glial cell line‐derived neurotrophic factor (GDNF) and its signaling receptor Ret are neuroprotective in toxin‐based animal models of PD. However, the mechanism by which GDNF/Ret protects cells from degenerating remains unclear. We investigated whether the Drosophila homolog of Ret can rescue Pink1 and park mutant phenotypes. We report that a signaling active version of Ret ( Ret MEN 2B ) rescues muscle degeneration, disintegration of mitochondria and ATP content of Pink1 mutants. Interestingly, corresponding phenotypes of park mutants were not rescued, suggesting that the phenotypes of Pink1 and park mutants have partially different origins. In human neuroblastoma cells, GDNF treatment rescues morphological defects of PINK1 knockdown, without inducing mitophagy or Parkin recruitment. GDNF also rescues bioenergetic deficits of PINK knockdown cells. Furthermore, overexpression of Ret MEN 2B significantly improves electron transport chain complex I function in Pink1 mutant Drosophila . These results provide a novel mechanism underlying Ret‐mediated cell protection in a situation relevant for human PD. ![][1] Glial cell line derived neurotrophic factor (GDNF) improves survival in toxin‐models of Parkinson's disease and is currently undergoing clinical development, however the protective mechanism is elusive. This study provides evidence that the GDNF receptor Ret rescues defects of a genetic Parkinson model and proposes a new mechanism‐of‐action. EMBO Journal (2014) 33, 341–355 [1]: pending:yesKeywords
Funding Information
- Deutsche Forschungsgemeinschaft
- European Commission
- European Research Council
This publication has 78 references indexed in Scilit:
- PINK1 and Parkin Target Miro for Phosphorylation and Degradation to Arrest Mitochondrial MotilityCell, 2011
- Mitochondrially localized PKA reverses mitochondrial pathology and dysfunction in a cellular model of Parkinson's diseaseCell Death & Differentiation, 2011
- PARIS (ZNF746) Repression of PGC-1α Contributes to Neurodegeneration in Parkinson's DiseaseCell, 2011
- Parkin is transcriptionally regulated by ATF4: evidence for an interconnection between mitochondrial stress and ER stressCell Death & Differentiation, 2010
- Rapamycin activation of 4E-BP prevents parkinsonian dopaminergic neuron lossNature Neuroscience, 2009
- Parkinson's disease mutations in PINK1 result in decreased Complex I activity and deficient synaptic functionEMBO Molecular Medicine, 2009
- PINK1-Associated Parkinson's Disease Is Caused by Neuronal Vulnerability to Calcium-Induced Cell DeathMolecular Cell, 2009
- Pink1 Forms a Multiprotein Complex with Miro and Milton, Linking Pink1 Function to Mitochondrial TraffickingBiochemistry, 2009
- Hypersensitivity to oxygen and shortened lifespan in a Drosophila mitochondrial complex II mutantProceedings of the National Academy of Sciences, 2006
- Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by ParkinProceedings of the National Academy of Sciences, 2006